Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.61 |
| ▸ | AIP | O00170 | 1/20 | 0.54 |
| ▸ | SGTA | O43765 | 1/20 | 0.54 |
| ▸ | TOMM70 | O94826 | 1/20 | 0.54 |
| ▸ | STIP1 | P31948 | 1/20 | 0.54 |
| ▸ | PPP5C | P53041 | 1/20 | 0.54 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.54 |
| ▸ | PPID | Q08752 | 1/20 | 0.54 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.54 |
| ▸ | FKBP8 | Q14318 | 1/20 | 0.54 |
| ▸ | TOMM34 | Q15785 | 1/20 | 0.54 |
| ▸ | DNAJC7 | Q99615 | 1/20 | 0.54 |
| ▸ | AIPL1 | Q9NZN9 | 1/20 | 0.54 |
| ▸ | STUB1 | Q9UNE7 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18180597 | 0.85 | L3MBTL1 (0.66) | MAPTKMT2AMEN1MAPK8AIP | |
| SCHEMBL3914715 | 0.79 | FLT3 (0.74) | MAPTKMT2AMEN1MAPK8L3MBTL1 | |
| SCHEMBL5453629 | 0.75 | PDE4B (0.65) | MAPTKMT2AMEN1L3MBTL1ALDH1A1 | |
| SCHEMBL5449182 | 0.74 | PDE4B (0.64) | MAPTKMT2AMEN1MAPK8AIP | |
| SCHEMBL28818013 | 0.71 | ALDH1A1 (0.76) | MAPTKMT2AMEN1AIPSGTA | |
| SCHEMBL31060214 | 0.70 | MAPK8 (1.00) | MAPTKMT2AMEN1MAPK8AIP | |
| SCHEMBL2494960 | 0.69 | KMT2A (0.59) | MAPTKMT2AMEN1MAPK8L3MBTL1 | |
| SCHEMBL990297 | 0.69 | ALDH1A1 (0.60) | MAPTKMT2AMEN1MAPK8L3MBTL1 | |
| SCHEMBL8104093 | 0.68 | KMT2A (0.49) | MAPTKMT2AMEN1MAPK8L3MBTL1 | |
| SCHEMBL4733997 | 0.68 | KMT2A (1.00) | MAPTKMT2AMEN1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016172545-A1 | CASTRATION-RESISTANT PROSTATE CANCER | NUTECH VENTURES (US) | 2016-10-27 | — | — | WO | disclosed |
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | NUTECH VENTURES | 2016-10-27 | — | — | US | disclosed |
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | NUTECH VENTURES | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | UGDH, G6PD, DPYD | MAPT 2722/4885KMT2A 1415/4885MEN1 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.